Clearside Biomedical, Inc.
General ticker "CLSD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $794.1M (TTM average)
Clearside Biomedical, Inc. does not follow the US Stock Market performance with the rate: -34.2%.
Estimated limits based on current volatility of 5.3%: low 0.38$, high 0.63$
Factors to consider:
- Total employees count: 30 (-16.7%) as of 2023
- Top business risk factors: Operational and conduct risks, Intellectual property risks, Regulatory and compliance, Geopolitical risks, Climate change and natural disasters
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.96$, 22.71$]
- 2024-12-30 to 2025-12-30 estimated range: [5.81$, 17.27$]
Financial Metrics affecting the CLSD estimates:
- Negative: with PPE of -30.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -26.92 <= 0.33
- Negative: Shareholder equity ratio, % of -46.78 <= 18.93
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
Short-term CLSD quotes
Long-term CLSD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $29.57MM | $1.33MM | $8.23MM |
| Operating Expenses | $30.20MM | $31.60MM | $33.07MM |
| Operating Income | $-0.63MM | $-30.28MM | $-24.84MM |
| Non-Operating Income | $1.00MM | $-2.67MM | $-7.64MM |
| Interest Expense | $0.00MM | $3.34MM | $9.36MM |
| R&D Expense | $18.54MM | $19.63MM | $20.85MM |
| Income(Loss) | $0.38MM | $-32.95MM | $-32.48MM |
| Profit(Loss)* | $0.38MM | $-32.95MM | $-32.48MM |
| Stockholders Equity | $37.98MM | $10.61MM | $-15.91MM |
| Inventory | $0.92MM | $0.00MM | $0.00MM |
| Assets | $42.90MM | $51.30MM | $34.02MM |
| Operating Cash Flow | $-10.73MM | $-13.37MM | $-18.14MM |
| Capital expenditure | $0.00MM | $0.25MM | $1.78MM |
| Investing Cash Flow | $0.00MM | $-0.25MM | $-1.78MM |
| Financing Cash Flow | $23.78MM | $31.33MM | $0.41MM |
| Earnings Per Share** | $0.10 | $-8.21 | $-7.88 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.